scPharmaceuticals Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
scPharmaceuticals Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2017 to Q3 2024.
  • scPharmaceuticals Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.33M, a 13.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.33M -$205K -13.4% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $1.31M +$946K +261% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $1.36M +$889K +191% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.4M +$835K +148% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $1.54M +$858K +127% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $363K -$422K -53.8% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $466K +$148K +46.5% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $566K +$156K +38% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $677K +$164K +32% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $785K +$169K +27.4% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $318K -$399K -55.6% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $410K -$405K -49.7% Dec 31, 2021 10-K 2023-03-22
Q3 2021 $513K -$397K -43.6% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $616K -$386K -38.5% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $717K -$375K -34.3% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $815K -$364K -30.9% Dec 31, 2020 10-K 2022-03-22
Q3 2020 $910K -$354K -28% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $1M -$345K -25.6% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $1.09M -$335K -23.5% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $1.18M -$327K -21.7% Dec 31, 2019 10-K 2021-03-23
Q3 2019 $1.26M -$318K -20.1% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $1.35M -$282K -17.3% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $1.43M -$275K -16.2% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $1.51M -$267K -15.1% Dec 31, 2018 10-K 2020-03-24
Q3 2018 $1.58M Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $1.63M Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $1.7M Mar 31, 2018 10-Q 2018-05-07
Q4 2017 $1.77M Dec 31, 2017 10-K 2019-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.